Veronica Vassia

9PUBLICATIONS
167CO-AUTHORS
Medical infection agents (incl. prions)Intensive careMedical bacteriologyPredictive and prognostic markersFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 25, 2026
Source Control in Pseudomonas aeruginosa Bloodstream Infections: An Overlooked Pillar in Reducing 30-Day All-Cause Mortality.

|May 04, 2026
Higher 25(OH)D Levels at Admission Predict a Favorable Disease Evolution in Moderate-to-Severe COVID-19 Patients.

|Jul 28, 2025
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections.

Nicholas Geremia, Federico Giovagnorio, Antonio Vena

|Sep 03, 2024
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study.

Antonio Vena, Michela Schenone, Silvia Corcione

|Mar 30, 2023
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients.

Stelvio Tonello, Davide D'Onghia, Daria Apostolo

|Mar 11, 2023
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial.

Erica Matino, Elena Tavella, Manuela Rizzi

Pageof 2

Frequent Collaborators

6 joint publications

Stelvio Tonello

6 joint publications

Pier Paolo Sainaghi

6 joint publications

Luigi Mario Castello

5 joint publications

Manuela Rizzi